0001104659-24-074574.txt : 20240625 0001104659-24-074574.hdr.sgml : 20240625 20240625084501 ACCESSION NUMBER: 0001104659-24-074574 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240625 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240625 DATE AS OF CHANGE: 20240625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RIGEL PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001034842 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943248524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-29889 FILM NUMBER: 241066268 BUSINESS ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-624-1100 MAIL ADDRESS: STREET 1: 611 GATEWAY BOULEVARD, SUITE 900 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 8-K 1 tm2417992d1_8k.htm FORM 8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 25, 2024

RIGEL PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

Delaware

(State or other jurisdiction of incorporation)

0-29889		94-3248524
(Commission File No.)		(IRS Employer Identification No.)

611 Gateway Boulevard, Suite 900
South San Francisco, CA		94080
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code: (650) 624-1100

Not Applicable

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
Common Stock, par value $0.001 per share		RIGL		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 8.01.

Other Events.

On June 25, 2024, Rigel Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issued a press release announcing that its board of directors has approved a one-for-10 reverse stock split (the “Reverse Stock Split”) of the Company’s common stock, par value $0.001. A copy of the press release is filed herewith as Exhibit 99.1 and is incorporated by reference into this Item 8.01.

The Reverse Stock Split is expected to become effective on June 27, 2024 as of 12:01 a.m. Eastern Time (the “Effective Time”), with shares to begin trading on a split-adjusted basis at market open on June 27, 2024. In connection with the Reverse Stock Split, every 10 shares of the Company’s common stock issued and outstanding as of the Effective Time will be automatically converted into one share of the Company’s common stock. The Company’s stockholders will be entitled to receive the cash value equal to the fraction to which the stockholder would otherwise be entitled, multiplied by the closing price of the Common Stock, as reported by Nasdaq, on the last trading day prior to the effective date of the Reverse Stock Split.

As a result of the Reverse Stock Split, proportionate adjustments will be made to the number of shares of the Company’s common stock underlying the Company’s outstanding equity awards and the number of shares issuable under the Company’s equity incentive plans and other existing agreements, as well as the exercise or conversion price, as applicable.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits.

Exhibit No.		Description

99.1		Press release, dated June 25, 2024

104		Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 25, 2024	RIGEL PHARMACEUTICALS, INC.

	By:	/s/ Raymond J. Furey
		Raymond J. Furey
		Executive Vice President, General Counsel, Chief Compliance Officer, and Corporate Secretary

EX-99.1 2 tm2417992d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

Rigel Announces Reverse Stock Split

SOUTH SAN FRANCISCO, Calif., June 25, 2024 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will effect a reverse stock split of its issued and outstanding shares of common stock at a ratio of 1-for-10 (the “Reverse Stock Split”), effective at 12:01 a.m. Eastern Time on Thursday, June 27, 2024. The company’s common stock will begin trading on a post-split basis on The Nasdaq Global Select Market under the same symbol (RIGL) when the market opens on Thursday, June 27, 2024, with the new CUSIP number 766559702.

The Reverse Stock Split was approved by the company’s stockholders at its Annual Meeting of Stockholders held on May 24, 2024 to be effected by the company’s Board of Directors (the “Board”) within approved parameters. The final ratio was approved by the Board on June 15, 2024. As a result of the Reverse Stock Split, every 10 shares of the company’s pre-split common stock issued and outstanding will be automatically reclassified into one new share of the company’s common stock. This will reduce the number of shares outstanding from approximately 175,582,945 shares to approximately 17,558,294, subject to adjustment due to the payment of cash in lieu of fractional shares. Proportionate adjustments will be made to the exercise prices and the number of shares underlying the company’s equity plans, as applicable. The Reverse Stock Split will not affect the number of authorized shares of common stock or the par value of the common stock.

The primary objective in effectuating the Reverse Stock Split will be to attempt to raise the per-share trading price of the company’s common stock. Rigel believes that the low per-share market price of its common stock impairs the company’s marketability to, and acceptance by, institutional investors and other members of the investing public and creates a negative impression of the company. Among other benefits, the Reverse Stock Split will also help the company to maintain compliance with the minimum bid continued listing requirement of $1.00 per share required to maintain continued listing on The Nasdaq Global Select Market.

Equiniti Trust Company, LLC, is acting as the exchange agent for the Reverse Stock Split. Registered stockholders holding pre-split shares of the company's common stock electronically in book-entry form are not required to take any action to receive post-split shares. Stockholders owning shares in "street name" or via a broker, bank, trust or other nominee will have their positions automatically adjusted to reflect the Reverse Stock Split, subject to the particular processes of such broker, bank, trust or other nominee, and will not be required to take any action in connection with the Reverse Stock Split. Stockholders holding shares of the company's common stock in certificate form will receive a transmittal letter from Equiniti with instructions as soon as practicable after the effective date. No fractional shares will be issued in connection with the Reverse Stock Split. Stockholders who otherwise would be entitled to receive fractional shares will receive a cash payment in lieu of such fractional shares.

Additional information regarding the Reverse Stock Split is available on the Form 8-K filed today, as well as in the company’s definitive proxy statement filed with the Securities and Exchange Commission on April 10, 2024, a copy of which is available at www.sec.gov and on the company's website.

About Rigel

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. Founded in 1996, Rigel is based in South San Francisco, California. For more information on Rigel, the company's marketed products and pipeline of potential products, visit www.rigel.com.

Forward Looking Statements

This press release contains forward-looking statements relating to, among other things, future Rigel stock price, expected market impact on Rigel stock, expectations related to the potential and market opportunity of Rigel stock, the effect of the Reverse Stock Split on marketability to and acceptance by institutional investors and other members of the investing public and impressions of the company in the market, the effect of the Reverse Stock Split on Rigel stock and stockholders, our ability to maintain compliance with the Nasdaq continued listing requirements, and Rigel’s future performance. Any statements contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements can be identified by words such as "plan", "potential", "may", "expects", "will" and similar expressions in reference to future periods. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on Rigel's current beliefs, expectations, and assumptions and hence they inherently involve significant risks, uncertainties and changes in circumstances that are difficult to predict and many of which are outside of our control. Therefore, you should not rely on any of these forward-looking statements. Actual results and the timing of events could differ materially from those anticipated in such forward looking statements as a result of these risks and uncertainties, which include, without limitation, risks and uncertainties associated with our ability to maintain compliance with Nasdaq's continued listing requirements, including the minimum bid price requirement of $1.00 per share; as well as other risks detailed from time to time in Rigel's reports filed with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the year ended December 31, 2023 and subsequent filings. Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Rigel does not undertake any obligation to update forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise, and expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein, except as required by law.

Contact for Investors & Media:

Investors:
Rigel Pharmaceuticals, Inc.
650.624.1232
ir@rigel.com

Media:
David Rosen
Argot Partners
212.600.1902
david.rosen@argotpartners.com

EX-101.SCH 3 rigl-20240625.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 rigl-20240625_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 rigl-20240625_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 6 tm2417992d1_ex99-1img001.jpg GRAPHIC begin 644 tm2417992d1_ex99-1img001.jpg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end XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2

Cover

Jun. 25, 2024

Cover [Abstract]

Document Type 8-K

Amendment Flag false

Document Period End Date Jun. 25, 2024

Entity File Number 0-29889

Entity Registrant Name RIGEL PHARMACEUTICALS, INC.

Entity Central Index Key 0001034842

Entity Tax Identification Number 94-3248524

Entity Incorporation, State or Country Code DE

Entity Address, Address Line One 611 Gateway Boulevard

Entity Address, Address Line Two Suite 900

Entity Address, City or Town South San Francisco

Entity Address, State or Province CA

Entity Address, Postal Zip Code 94080

City Area Code 650

Local Phone Number 624-1100

Written Communications false

Soliciting Material false

Pre-commencement Tender Offer false

Pre-commencement Issuer Tender Offer false

Title of 12(b) Security Common Stock, par value $0.001 per share

Trading Symbol RIGL

Security Exchange Name NASDAQ

Entity Emerging Growth Company false

X

- Definition
Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
No definition available.
+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Area code of city
+ References
No definition available.
+ Details

Name: dei_CityAreaCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Cover page.
+ References
No definition available.
+ Details

Name: dei_CoverAbstract

Namespace Prefix: dei_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition
For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
No definition available.
+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition
The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
No definition available.
+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 1 such as Attn, Building Name, Street Name
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine1

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Address Line 2 such as Street or Suite number
+ References
No definition available.
+ Details

Name: dei_EntityAddressAddressLine2

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the City or Town
+ References
No definition available.
+ Details

Name: dei_EntityAddressCityOrTown

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Code for the postal or zip code
+ References
No definition available.
+ Details

Name: dei_EntityAddressPostalZipCode

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the state or province.
+ References
No definition available.
+ Details

Name: dei_EntityAddressStateOrProvince

Namespace Prefix: dei_

Data Type: dei:stateOrProvinceItemType

Balance Type: na

Period Type: duration

X

- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition
Indicate if registrant meets the emerging growth company criteria.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityEmergingGrowthCompany

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
No definition available.
+ Details

Name: dei_EntityFileNumber

Namespace Prefix: dei_

Data Type: dei:fileNumberItemType

Balance Type: na

Period Type: duration

X

- Definition
Two-character EDGAR code representing the state or country of incorporation.
+ References
No definition available.
+ Details

Name: dei_EntityIncorporationStateCountryCode

Namespace Prefix: dei_

Data Type: dei:edgarStateCountryItemType

Balance Type: na

Period Type: duration

X

- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b-2
+ Details

Name: dei_EntityTaxIdentificationNumber

Namespace Prefix: dei_

Data Type: dei:employerIdItemType

Balance Type: na

Period Type: duration

X

- Definition
Local phone number for entity.
+ References
No definition available.
+ Details

Name: dei_LocalPhoneNumber

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 13e
-Subsection 4c
+ Details

Name: dei_PreCommencementIssuerTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 14d
-Subsection 2b
+ Details

Name: dei_PreCommencementTenderOffer

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Title of a 12(b) registered security.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection b
+ Details

Name: dei_Security12bTitle

Namespace Prefix: dei_

Data Type: dei:securityTitleItemType

Balance Type: na

Period Type: duration

X

- Definition
Name of the Exchange on which a security is registered.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Number 240
-Section 12
-Subsection d1-1
+ Details

Name: dei_SecurityExchangeName

Namespace Prefix: dei_

Data Type: dei:edgarExchangeCodeItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Exchange Act
-Section 14a
-Number 240
-Subsection 12
+ Details

Name: dei_SolicitingMaterial

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition
Trading symbol of an instrument as listed on an exchange.
+ References
No definition available.
+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: dei:tradingSymbolItemType

Balance Type: na

Period Type: duration

X

- Definition
Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ References
Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher SEC
-Name Securities Act
-Number 230
-Section 425
+ Details

Name: dei_WrittenCommunications

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://rigel.com/role/Cover Cover Cover 1 false false All Reports Book All Reports rigl-20240625.xsd rigl-20240625_lab.xml rigl-20240625_pre.xml tm2417992d1_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "tm2417992d1_8k.htm": { "nsprefix": "rigl", "nsuri": "http://rigel.com/20240625", "dts": { "schema": { "local": [ "rigl-20240625.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "rigl-20240625_lab.xml" ] }, "presentationLink": { "local": [ "rigl-20240625_pre.xml" ] }, "inline": { "local": [ "tm2417992d1_8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://rigel.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-06-25", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2417992d1_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-06-25", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "p", "body", "html" ], "reportCount": 1, "baseRef": "tm2417992d1_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://rigel.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001104659-24-074574-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-24-074574-xbrl.zip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end XML 18 tm2417992d1_8k_htm.xml IDEA: XBRL DOCUMENT 0001034842 2024-06-25 2024-06-25 iso4217:USD shares iso4217:USD shares false 0001034842 8-K 2024-06-25 RIGEL PHARMACEUTICALS, INC. DE 0-29889 94-3248524 611 Gateway Boulevard Suite 900 South San Francisco CA 94080 650 624-1100 false false false false Common Stock, par value $0.001 per share RIGL NASDAQ false